Skip to main content
. 2021 Apr 14;13(2):145–151. doi: 10.5114/jcb.2021.105281

Table 2.

SpaceOAR vs. no SpaceOAR, categorical variables

Categorical variable No SpaceOAR SpaceOAR Total p-value*
n % n % n %
Clinical stage T1c 134 77.0 123 70.7 257 73.8 0.349
T2a 26 14.9 34 19.5 60 17.2
T2b 9 5.2 8 4.6 17 4.9
T2c 5 2.9 4 2.3 9 2.6
T3a,b,c 0 0.0 5 2.9 5 1.4
103Pd implant Rx dose (Gy) 80 90 51.7 106 60.9 196 56.3 0.005
90 22 12.6 34 19.5 56 16.1
115 29 16.7 22 12.6 51 14.7
125 33 19.0 12 16.9 45 12.9
NCCN Risk Group Low 3 1.7 0 0.0 3 0.9 0.061
Intermediate 119 68.4 113 64.9 232 66.7
High 52 29.9 57 32.8 109 31.3
Very high 0 0.0 4 2.3 4 1.2
Diabetes No 173 99.4 174 100.0 347 99.7 0.317
Yes 1 0.6 0 0.0 1 0.3
Hypercholesterolemia No 172 98.8 174 100.0 346 99.4 0.156
Yes 2 1.2 0 0.0 2 0.6
Hypertension No 171 98.3 174 100.0 345 99.1 0.082
Yes 3 1.7 0 0.0 3 0.9

Chi-squared test, p-values ≤ 0.5 in bold